Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Inno Stock Surges 20-Fold on AI Deal, but Risks Loom
Markets Daniel Marsh

Inno Stock Surges 20-Fold on AI Deal, but Risks Loom

Inno Holdings stock soared nearly 20x to $20.97 on a $3M AI deal for used phones, but a $60M at-the-market offering and going-concern doubts temper the rally.

INHD
Emirates Cuts A380 Service on 10 Routes as Fuel Costs and Airspace Issues Hit Airlines
Markets Daniel Marsh

Emirates Cuts A380 Service on 10 Routes as Fuel Costs and Airspace Issues Hit Airlines

Emirates cuts A380 flights on 10 routes as fuel costs and airspace issues pressure airlines. IATA lowers 2026 profit forecast to $23 billion, with capacity cuts and higher fares expected.

UAL LUV DAL AAL JBLU
Oklo Stock Rises on ARMEC Acquisition, July Test Reactor Milestone Looms
Markets Daniel Marsh

Oklo Stock Rises on ARMEC Acquisition, July Test Reactor Milestone Looms

Oklo shares rose 3% after acquiring ARMEC to expand in-house manufacturing, with July's test reactor criticality a key catalyst for the pre-revenue nuclear firm.

OKLO SO SMR
Wall Street Rebounds as Chip Stocks Rally Ahead of Key Inflation Report
Markets Daniel Marsh

Wall Street Rebounds as Chip Stocks Rally Ahead of Key Inflation Report

U.S. stocks rebounded Monday, driven by a rally in chip stocks, as the Dow gained 0.48% ahead of crucial May inflation data.

INTC MU NVDA SPY DIA QQQ GLD USO
Growth ETFs Rebound as Tech Rally Resumes, Concentration Risk in Focus
Markets Daniel Marsh

Growth ETFs Rebound as Tech Rally Resumes, Concentration Risk in Focus

Growth ETFs rose sharply Monday as tech stocks rebounded, with QQQ up 2.2% and VUG gaining 1.2%. The rally highlights strong AI-driven inflows but also concentration risk.

QQQ VUG VOO NVDA AAPL MSFT GOOGL AMZN META TSLA AVGO LLY
SCHD's Heavy Top Holdings Raise Red Flags for Safety Seekers
Markets Daniel Marsh

SCHD's Heavy Top Holdings Raise Red Flags for Safety Seekers

SCHD's top 10 holdings now make up 43.5% of assets, raising concentration risk. With a 3.24% yield and $95.17B in assets, the fund's safety profile is under scrutiny.

SCHD SPY QCOM TXN UNH CVX MRK KO COP AMGN PG VZ JPM XOM JNJ
Chip Stocks Surge on Intel-Google Deal, Nasdaq Jumps Ahead of CPI
Markets Daniel Marsh

Chip Stocks Surge on Intel-Google Deal, Nasdaq Jumps Ahead of CPI

Chip stocks bounced back Monday, with Intel surging 8.5% on reports of a Google chip deal, powering a 1.43% Nasdaq gain ahead of Wednesday's key inflation data.

INTC GOOGL NVDA MU SPY QQQ GLD USO
Oil Surges, Tech Stocks Stabilize as Iran-Israel Conflict Eases
Markets Daniel Marsh

Oil Surges, Tech Stocks Stabilize as Iran-Israel Conflict Eases

U.S. stocks opened higher Monday, recovering from Friday's tech selloff, as oil prices spiked on Iran-Israel tensions but later eased on ceasefire signals.

USO SPY QQQ XLK SSNLF
AI Rally Faces Scrutiny as Wall Street Questions Profitability
Markets Daniel Marsh

AI Rally Faces Scrutiny as Wall Street Questions Profitability

U.S. stocks bounced back Monday after a chip-led $2 trillion rout, but investors are increasingly skeptical about AI spending delivering durable earnings amid rate hike fears.

AVGO NVDA GS C
QQQ Rebounds 1.6% After Steep Drop; Options Signal Caution
Markets Daniel Marsh

QQQ Rebounds 1.6% After Steep Drop; Options Signal Caution

QQQ bounces back 1.6% after a 4.8% selloff, with options data indicating trader caution rather than panic as Fed rate worries and AI spending concerns persist.

QQQ SPY QQQ
Leveraged Chip ETF Bounces After Record Plunge, But Risks Remain
Markets Daniel Marsh

Leveraged Chip ETF Bounces After Record Plunge, But Risks Remain

SOXL jumped 15% Monday after a 30.5% plunge, as chip stocks rebounded. Direxion warns these leveraged ETFs reset daily, making them short-term trades, not long-term bets.

SOXX SMH NVDA MU MRVL AMD AVGO
Tango Therapeutics Soars as Pancreatic Cancer Combo Shows 92% Response Rate
Markets Daniel Marsh

Tango Therapeutics Soars as Pancreatic Cancer Combo Shows 92% Response Rate

Tango Therapeutics shares rose sharply in premarket trading Monday after reporting a 92% objective response rate for its pancreatic cancer drug combo, with plans to move into Phase 3 testing.

TNGX RVMD